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Rift Valley Fever (RVF) virus is an arbovirus and is responsible for large outbreaks of disease predominantly in sub-Saharan
Africa. However, several aspects of RVF virus transmission, such as high viremia, multiple vector species, and broad host
range, result in a pathogen with high likelihood of geographic spread. RVF virus infection in humans and livestock is
characterized by broad dissemination of RVF virus antigens throughout the body. We sought insight into the high pathoge-
nicity and broad tropism of this virus through a characterization of its interaction with polarized epithelial cells. Our results
indicate that infection and release of RVF virus in polarized epithelial cells occurs at both apical and basolateral membranes
and hence is bidirectional. Furthermore, our results indicate that RVF virus causes disruptions in both the microfilament and
the microtubule networks. These disruptions may provide a mechanism for bidirectional release of RVF virions. © 2002 ElsevierINTRODUCTION
Rift Valley Fever (RVF) virus causes large periodic
outbreaks of disease in both humans and livestock (Mor-
rill and McClain, 1996). Outbreaks are often associated
with periods of unusually high rainfall that result in the
creation of breeding habitats for floodwater mosquitoes
(Morrill and McClain, 1996; Linthicum et al., 1999). Aedes
mosquitoes are thought to be the major reservoir of RVF
virus (Gargan et al., 1988b). However, in the laboratory,
many species of mosquitoes can be infected with RVF
virus and are subsequently able to transmit the virus to a
vertebrate host (Gargan et al., 1988a; Gad et al., 1987;
Turell et al., 1996). Many common livestock species such
as cattle, goats, camels, and sheep can be infected by
RVF virus and develop extremely high viremias (Meegan,
1981). The ability of RVF virus to be vectored by many
different mosquito species, as well as the high viremias
which develop in infected animals, results in a pathogen
with high potential for geographic spread and mainte-
nance in nature. Until recently, outbreaks of RVF had
been confirmed only in sub-Saharan Africa; however,
epizootics in Egypt in 1977 and 1993 (Arthur et al., 1993;
Centers for Disease Control and Prevention, 1994; Mee-
gan, 1979) and another in Saudi Arabia and Yemen in
2000 (Centers for Disease Control and Prevention,
2000a,b) have clearly demonstrated the capacity of this
pathogen to spread into new regions.
RVF virus is a member of the family Bunyaviridae, and© 2002 Elsevier Science (USA)
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226like other members of this virus family, its genome is
composed of three negative-stranded RNA molecules.
RVF virus has four structural proteins: an RNA-depen-
dent RNA polymerase, two envelope glycoproteins, and
the nucleocapsid. Most, if not all, of the family Bunyaviri-
dae viruses are thought to mature by budding into the
lumen of the Golgi and are released from the cell when
elements of the Golgi fuse with the plasma membrane
(Pettersson and Melin, 1996). The glycoprotein precursor
of RVF virus is presumed to be processed by signal
peptidase in the endoplasmic reticulum into a nonstruc-
tural protein, NSM, and the envelope glycoproteins, G1
and G2 (Collett et al., 1985; Pettersson and Melin, 1996).
After being processed, G1 and G2 are thought to mul-
timerize and then localize in steady-state to the Golgi
apparatus by virtue of a Golgi localization motif present
in G2 (Wasmoen et al., 1988). Because RVF virus lacks a
matrix protein, the glycoproteins presumably recruit viral
ribonucleoprotein complexes and commence budding
into the lumen of the Golgi. It is unclear how the virion-
containing Golgi elements are induced to fuse with the
plasma membrane. It also remains an open question
whether these Golgi elements contain targeting informa-
tion, as is the case for cellular secretory vesicles, direct-
ing release in a polarized fashion.
Epithelial cells are divided into two domains, apical
and basolateral, which are compositionally distinct and
kept separate by the tight junction (Ikonen and Simons,
1998). The apical domain faces the lumen of the organ
and the basolateral domain the basement membrane.Science (USA)
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Vesicular traffic from the trans-Golgi network to the
plasma membrane is polarized and distinct signalsd epith
within apical and basolateral proteins direct their target-
ing to the appropriate surface of the cell. The cytoskel-
eton of the cell plays a vital role in the transport of
vesicles to their appropriate destinations (Mays et al.,
1994; Lippincott-Schwartz, 1998; Rogers and Gelfand,
2000; Hamm-Alvarez and Sheetz, 1998). In general, en-
veloped viruses that mature in a polarized manner utilize
the cellular trafficking machinery to target their envelope
glycoproteins to the appropriate cell surface. However,
viruses of the family Bunyaviridae typically mature in the
Golgi apparatus, making it impossible to predict polarity
of release based on localization of envelope glycopro-
teins. Prior to this report, two viruses of the family Bun-
yaviridae, Punta Toro (Chen et al., 1991) and Black Creek
Canal (Ravkov et al., 1997) viruses, were shown to be
released in a polarized fashion. It is not clear how this
polarity of release is achieved, nor is it known whether
polarized release is a general phenomenon of members
of the family Bunyaviridae.
Humans can be infected with RVF virus by either
mosquito bite or aerosol inhalation. Aerosol transmis-
sion occurs typically from exposure to blood from in-
fected animals, for instance, during the slaughter of in-
fected animals or from contact with tissues resulting
from RVF-induced abortion in livestock. In both infected
livestock and humans, RVF virus produces a broadly
disseminated infection. Although the liver appears to be
a major site of replication, RVF virus can be isolated from
all organs of an infected animal (Peters et al., 1988;
Anderson et al., 1987). In addition, RVF virus can infect, in
culture, a broad range of cell types isolated from a wide
variety of organisms (Peters and Anderson, 1981). These
data suggest that the receptor(s) for RVF virus is a ubiq-
uitous cellular component. To gain a better understand-
ing of the pathogenesis of RVF virus, we have charac-
terized the entrance and release of RVF virus in the
polarized epithelial cell line, Caco-2.
RESULTS
RVF virus release is not highly polarized
In an earlier study, RVF virus was observed maturing
from both the Golgi and the basolateral plasma mem-
brane (Anderson and Smith, 1987). Although the electron
microscopy data clearly indicated that a portion of the
released virion is released into the basolateral media,
the fate of the virus pool maturing in the Golgi was not
addressed. To assess the polarity of RVF virus release,
fully polarized Caco-2 monolayers grown on filters were
infected with RVF virus and release of progeny virus was
monitored in the apical and basolateral chambers from 8
to 20 h postinfection. Polarized Caco-2 cells were cho-
sen for these studies as they are well characterized with
regard to polarized secretion of cellular proteins, are
permissive for RVF virus infection, and develop a signif-
icant transepithelial resistance (TER) that allows verifi-
cation of the cell monolayer integrity during experiments.
This time course was chosen on the basis of preliminary
experiments that demonstrated that RVF virus release in
infected Caco-2 cells began around 8 h postinfection and
that cell monolayers began to show evidence of cyto-
pathic effect (CPE) around 24 h. Earlier studies of Punta
Toro virus (member of the genus Phlebovirus) infection of
polarized cells had successfully utilized 0.4-m-pore
Transwell filters. However, our initial experiments
showed that 0.4-m pores impeded diffusion of RVF
virus (and two additional members of the family Bunya-
viridae, Cache Valley and Garissa viruses), as unpolar-
ized Vero E6 cells grown on 0.4-m-pore filters were
approximately 100-fold more efficiently infected from the
apical chamber than the basal chamber (data not
shown). For this reason, all experiments with polarized
Caco-2 cells were done on 3.0-m-pore filters. No evi-
dence of cell migration through the pores could be seen
by confocal microscopy (data not shown). Figure 1A
shows a graph of infectious RVF virus recovered from the
apical and basolateral chambers, as well as cell-asso-
ciated virus, over the 20-h time course. The greatest
difference between the titer of apical and basolateral
medium was threefold. This value was essentially the
same for both the 16- and 20-h timepoints. In agreement
with our preliminary observations, we saw no evidence
of CPE over the course of our experiment as monitored
by visual inspection under a light microscope and TER
(Fig. 1B). Thus, there was no indication from this assay
that RVF virus release is strongly polarized, although the
monolayer remained polarized through the experimental
time course.
To address the issue of polarity of RVF virus release in
another way, we next developed an assay in which a
cellular protein that is released in a polarized fashion
could be monitored in the same samples as RVF virus
proteins. A potential source of error inherent to growing
cells on filters is that cells can migrate through the pores
in the filter. We saw no evidence of this occurring, as
monitored by microscopy (data not shown and Fig. 3).
However, a further control was included and consisted of
following secretion of a cellular protein that is normally
polarized. Caco-2 cells secrete a soluble form of the
extracellular matrix protein, fibronectin, predominantly to
the basolateral media (Low et al., 1994). Thus, secretion
of fibronectin can be used as a measure of both cell
polarity and monolayer integrity. Fully polarized Caco-2
or Vero cells were infected with RVF virus and subjected
to metabolic labeling. At 20 h postinfection, medium was
collected from apical and basolateral chambers and re-
leased RVF virus and fibronectin were immunoprecipi-
tated. In both mock- and RVF virus-infected cells, fi-
bronectin secretion was polarized to the same extent,
with approximately 5.5-fold more fibronectin being se-
creted into the basolateral media (Fig. 2B). By contrast,
RVF virus proteins were found to be approximately 6-fold
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more abundant in the apical chamber (Fig. 2A). The
preference for apical release of RVF virus is not an
artifact of growing cells on filters, since unpolarized Vero
cells grown on the same filters release equal amounts of
virus into the apical and basolateral chambers (Fig. 2C).
These results are consistent with the data presented in
Fig. 1: Caco-2 cells maintained their polarity throughout
the course of the experiment and there was a modest
preference for RVF virus release to the apical medium.
RVF virus envelope glycoproteins are detectable on
the basolateral, but not apical, plasma membrane
RVF virus glycoproteins localize in steady-state to the
Golgi apparatus (Wasmoen et al., 1988). Given that the
earlier electron microscopy data showed that RVF virus
matures, at least to a limited extent, on the basolateral
plasma membrane (Anderson and Smith, 1987), we
thought it likely that the glycoproteins may escape the
Golgi and localize to the plasma membrane at a certain
rate. We addressed this issue by assessing whether an
antibody against either G1 or G2 could be internalized
into RVF-virus-infected cells when added to either apical
or basolateral media. When RVF virus-infected cells are
exposed to either anti-G1 or -G2 antibodies in the apical
FIG. 2. RVF virus antigen accumulates in both apical and basolateral
media. Infected Caco-2 (A and B) or Vero E6 cells (C) were metaboli-
cally labeled with Tran35S-label from 4 to 20 h postinfection. RVF virus
proteins (A and C) and fibronectin (B) were immunoprecipitated from
apical and basolateral media at 20 h postinfection as described under
Materials and Methods. Band intensity was quantified using Image-
Quant and values represent the average relative intensity  the stan-
dard deviation; the standard deviation is given in parentheses.
FIG. 1. RVF virus release is modestly polarized to the apical surface.
Caco-2 cells were infected from both the apical and the basolateral
surface. Apical and basolateral media and cells were harvested at the
indicated times and the titer was determined by plaque assay (A). Prior
to harvest of cells and media, the TER was recorded (B). Titer and TER
values represent the average of at least three independent infections
and error bars correspond to the standard deviation.
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chamber, virtually no antibody is bound (Fig. 3). By con-
trast, when anti-G1 and -G2 antibodies are present in the
basolateral chamber, significant staining is observed
(Fig. 3). At this level of resolution, it is not possible to
discern whether the labeling represents plasma mem-
brane or endocytic membranes just underneath the
plasma membrane. Although RVF virus-infected cells
were incubated with anti-glycoprotein antibodies for 1 h,
sufficient time for a resident Golgi protein to recycle from
the plasma membrane (Ghosh et al., 1998), at no time did
we see Golgi labeling similar to that seen when G1 and
G2 antibodies are used to label permeabilized RVF virus-
infected cells (Fig. 3). This observation suggests that the
glycoproteins are not able to return from the plasma
membrane to the Golgi. Whether this is because G1 and
G2 lack Golgi retrieval signals or possibly because viral
ribonucleoprotein particles are rapidly recruited by G1
and G2 at the plasma membrane is not known.
RVF virus disrupts the microfilament and the
microtubule network
Many viruses are known to interfere with the cellular
polarity machinery and cause unpolarized release of
progeny virions from infected cells (Sodeik, 2000; Cud-
more et al., 1997). For instance, Sendai virus usually buds
apically, but a “pantropic” Sendai virus mutant buds in an
unpolarized fashion, a change that coincides with a gain
in ability of the mutant virus to disrupt the microtubule
network (Tashiro et al., 1990). As RVF virus is not re-
leased in a highly polarized fashion, we were interested
in whether RVF virus disrupted the cytoskeletal network.
At 20 h postinfection, cells were labeled with anti-RVF
virus antibodies and either microfilaments or microtu-
bules were labeled with phalloidin or anti-tubulin anti-
bodies, respectively (Fig. 4). Disruption of microfilaments
with actin depolymerizing agents, such as cytochalasin
D, results in a loss of TER (Madara et al., 1988). Although
we saw no drop in TER prior to 24 h post-RVF virus
infection (Fig. 1B), the microfilament network did appear
to be affected by RVF virus (Fig. 4). Instead of even
staining of actin at the cell periphery, cells infected with
RVF virus displayed a more punctate staining pattern
(Fig. 4). The microtubule network was also disrupted in
RVF virus-infected cells, as visualized by anti-tubulin
staining. Instead of the filamentous staining seen in
FIG. 3. RVF virus glycoproteins are found on basolateral plasma membrane. At 16 h postinfection, monoclonal antibodies to G1 or G2 were added
to either apical or basolateral medium. The infected cells were incubated at 37°C for 1 h in the presence of antibodies prior to fixation with
paraformaldehyde. Cells were permeabilized and the wells that were previously incubated with monoclonal antibody were incubated with Alexa
A488-conjugated anti-mouse antibody. Cells that were not incubated with monoclonal antibody prior to fixation were incubated with monoclonal
antibodies to either G1 or G2, followed by Alexa A488-conjugated anti-mouse antibody.
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mock-infected cells, many RVF virus-infected cells ap-
peared to contain aggregates of tubulin (Fig. 4).
RVF virus can infect Caco-2 cells from apical and
basolateral plasma membranes
Many viruses show a distinct polarity with respect to
entrance into host cells. These distinct differences re-
flect the relative distribution of viral receptors and other
entry cofactors. These differences also have a direct
impact on the pathogenesis of the virus, as the polarity of
entrance dictates where an infectious cycle can begin.
We exposed polarized Caco-2 monolayers to RVF virus in
either the apical or the basolateral chamber. At 16 h
postinfection, cells were analyzed for the presence of
RVF virus antigens. No qualitative difference was ob-
served in the amount of antigen present in apically or
basolaterally infected cells. Experiments were done sev-
eral times and in triplicate, with identical results obtained
in each case. Thus, it appears that RVF virus is capable
of infecting cells through both apical and basolateral
plasma membranes (Fig. 5).
Although it is clear that RVF virus can infect from either
apical or basolateral membranes, the experiment shown
in Fig. 5 does not address the relative efficiency of these
events. To address this issue, we infected Caco-2 cells
from either the apical or the basolateral side followed by
metabolic labeling of the infected cells. We found that
fourfold more RVF virus antigen was present in cells
infected through the apical side (Fig. 6A). Additionally, we
quantified fibronectin secretion into the apical and baso-
lateral media in the same infected monolayers. Fibronec-
tin secretion was polarized to the same extent in mock,
apical, and basolateral infected Caco-2 monolayers (Fig.
6B). To verify that the infection of cells is not inhibited in
any way by the filters used to grow the Caco-2 cells, we
also infected nonpolarized Vero cells grown on filters
from either the apical or the basolateral chamber. These
Vero cells accumulate antigen to an equal extent when
infected from either the apical or the basolateral side
(Fig. 6), suggesting that the filter is not a significant
impediment to RVF virus infection. These data are con-
sistent with the view that the receptor and entrance
machinery for RVF virus is expressed on both apical and
basolateral plasma membranes.
FIG. 4. RVF virus disrupts microtubules and microfilaments. Caco-2 cells were fixed with paraformaldehyde at 20 h postinfection. Cells were
incubated with human anti-RVF virus antibodies and either mouse anti-tubulin or A488 phalloidin followed by Alexa A568-conjugated anti-human
antibody and Alexa A488-conjugated anti-mouse antibody. Staining was visualized by confocal microscopy.
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DISCUSSION
The interaction of a virus with polarized epithelia in the
host has direct consequences on the spread and course
of an infection (Compans, 1995; Tashiro et al., 1990). We
have found that RVF virus can enter Caco-2 cells from
either apical or basolateral plasma membranes. These
results are entirely consistent with the modes of trans-
mission of RVF virus. RVF virus can infect humans
through aerosol particles generated from infected blood
or tissue, where RVF virus would first come in contact
with the apical domain of lung epithelia. RVF virus can
also infect hosts through mosquito bite, in which RVF
virus would presumably enter the blood stream and have
access to the apical domain of cells lining blood vessels
followed by release into the underlying tissues. Addition-
ally, we found that release of RVF virus was only weakly
polarized toward the apical plasma membrane. Substan-
tial amounts of virus are shed from the basolateral
plasma membrane, allowing access to the blood stream
and hence dissemination of infection. Thus, our obser-
FIG. 5. RVF virus antigen accumulates in Caco-2 cells infected from either apical or basolateral plasma membranes. Caco-2 cells were fixed with
paraformaldehyde at 16 h postinfection. Cells were permeabilized and then incubated with polyclonal anti-RVF virus antibodies followed by Alexa
A488-conjugated anti-mouse antibody. Staining was visualized by confocal microscopy.
FIG. 6. Quantification of RVF virus antigen accumulation in Caco-2 cells infected from either apical or basolateral plasma membranes. Infected
Caco-2 or Vero cells were metabolically labeled with Tran35S-label from 16 to 20 h postinfection. RVF virus proteins were immunoprecipitated from
cell extracts at 20 h postinfection (A). Fibronectin was immunoprecipitated from apical and basolateral media at 20 h postinfection (B). Band intensity
was quantified using ImageQuant and values represent the average relative intensity; the standard deviation is given in parentheses.
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vations in cultured polarized epithelia are consistent with
what is observed in natural host infection.
RVF virus has been reported to mature both intracel-
lularly in the Golgi and at the basolateral plasma mem-
brane of primary rat hepatocytes (Anderson and Smith,
1987). Consistent with this observation in primary rat
hepatocytes, we found that RVF virus glycoproteins ac-
cumulate both intracellularly in the Golgi and on the
basolateral plasma membrane in Caco-2 cells. There-
fore, it seems unlikely that our observations are cell-type
specific. Although the glycoproteins are localized in a
highly polarized fashion, release of virus is only modestly
polarized with more virus released into the apical media.
While we cannot separate the fates of intracellularly
maturing virus versus basolaterally maturing virus with
the assays shown in this report, it is interesting to note
that the apically released virus must have come from the
intracellularly maturing viral pool. Thus, it is possible that
intracellularly maturing virus is released in a polarized
fashion.
Directional transport of secreted proteins is depen-
dent on microtubule networks (Lafont et al., 1994; Mays
et al., 1994; Lippincott-Schwartz, 1998). Motor proteins,
such as dynein and kinesin, are involved in the move-
ment of transport vesicles along microtubules in a polar-
ized fashion (Lafont et al., 1994). Many viruses have been
shown to disrupt the microtubule network, including vac-
cinia (Ploubidou et al., 2000), African swine fever virus
(Alonso et al., 2001), cytomegalovirus (Fish et al., 1996)
and herpes simplex virus (Avitabile et al., 1995; Topp et
al., 1994). It is not surprising that many intracellularly
maturing viruses have evolved mechanisms for interact-
ing with the microtubule network, given the role micro-
tubules play in vesicular transport. Disruption of the
microtubule network with agents that depolymerize tu-
bulin, such as colchicine and nocodazole, has a pro-
found effect on the morphology of the Golgi apparatus
(Rogalski and Singer, 1984; Cole et al., 1996; Lippincott-
Schwartz, 1998). All of the above-mentioned viruses, in-
cluding RVF virus, disrupt the morphology of the Golgi
apparatus prior to significant CPE (Avitabile et al., 1995;
Fish et al., 1996; Ploubidou et al., 2000; Morrill and
McClain, 1996; Rietdorf et al., 2001; McCrossan et al.,
2001). It is interesting to speculate on the how disruption
of the microtubule network may benefit RVF virus. Per-
haps the disruption of microtubules allows for better
dissemination of RVF virus by allowing the migration of
RVF virus-containing Golgi elements to the cell periphery.
Punta Toro virus belongs to the same genus (Phlebo-
virus) as RVF virus. In contrast to the lack of marked
polarity seen in RVF virus release, Punta Toro virus
release is highly polarized, with approximately 10,000-
fold more virus being released into the basolateral than
the apical media (Chen et al., 1991). Black Creek Canal
virus, another member of the family Bunyaviridae, is also
released in a polarized fashion with approximately 1000-
fold more virus being released in the apical than the
basolateral media (Ravkov et al., 1997). Furthermore,
unlike RVF virus, Punta Toro virus glycoproteins do not
accumulate on the plasma membrane (Chen and Com-
pans, 1991). As the family Bunyaviridae lack matrix pro-
teins, and at least for RVF virus the nucleocapsid has no
inherent affinity for the Golgi or plasma membrane
(manuscript in preparation), the envelope glycoproteins
are likely to be solely responsible for determining the site
of maturation. Punta Toro virus and RVF virus envelope
glycoproteins show significant overall amino acid simi-
larity. However, there is considerable sequence differ-
ence in the transmembrane and cytosolic tail regions of
the N-terminal glycoprotein (G2 for RVF virus and G1 for
Punta Toro virus), which is the glycoprotein thought to be
responsible for Golgi localization (Ihara et al., 1985)
(manuscript in preparation). These differences may be
responsible for the different release characteristics of
these viruses. We are currently investigating the local-
ization determinants in the G2 glycoprotein of RVF virus,
since these determinants are likely to be important for
understanding the different maturation and release strat-
egies of RVF virus and Punta Toro virions.
The polarity of viral entrance is determined by the
distribution of cellular factors involved in the binding of
virus and uptake into cells. Apical and basolateral
plasma membranes have distinct protein and lipid con-
tent and as a result many viruses are polarized with
respect to entry into cells (Compans, 1995; Ikonen and
Simons, 1998). RVF virus can infect cells from either
apical or basolateral plasma membranes; thus, cellular
factors used by RVF virus to enter polarized epithelia are
present on both apical and basolateral membranes. In
addition, RVF virus can infect a broad array of tissues in
animals and in its insect vectors. While we do not know
the identity of any of the receptor(s) for RVF virus, the
broad tissue and host specificity as well as the lack of
polarity suggest that these must be ubiquitous mole-
cules.
MATERIALS AND METHODS
Materials
All cell culture medium was purchased from Gibco
(Carlsbad, CA) except as otherwise noted. Caco-2 cells
(HTB-37) were purchased from American Type Culture
Collection (Manassus, VA). Minimal essential media
(MEM) lacking cysteine and methionine and Tran35S-
label was purchased from ICN (Costa Mesa, CA). Protein
G–Sepharose 4B was obtained from Sigma (St. Louis,
MO). Costar Transwells were purchased from Fisher
Scientific (Marietta, GA). Rabbit anti-fibronectin antibody
was from Calbiochem (San Diego, CA). Alexa A488-con-
jugated anti-mouse antibody, Alexa A568 anti-human an-
tibody, anti-tubulin monoclonal antibody, and Alexa A488
phalloidin were purchased from Molecular Probes (Eu-
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gene, OR). The EVOM voltmeter and STX probes were
purchased from World Precision Instruments (Sarasota,
FL). Monoclonal antibodies to G1 (R4-6G4-1-1) and G2
(R5-3G2-1A) RVF virus glycoproteins were a generous
gift from Jonathan Smith at the U.S. Army Medical Re-
search Institute of Infectious Diseases (USAMRIID). The
mouse anti-RVF virus polyclonal antibody was made by
Thomas Ksiazek at the Centers for Disease Control and
Prevention (CDC). Human anti-RVF virus serum was ob-
tained from an individual naturally infected with RVF
virus.
Cell lines and culture
Caco-2 cells were grown in Dulbecco’s modified Ea-
gle’s medium supplemented with 20% fetal calf serum
(FCS), 1% nonessential amino acids, and antibiotics (100
mU/mL penicillin G and 100 g/mL streptomycin sulfate).
Vero cells were grown in MEM with Earle’s salts supple-
mented with 10% FCS and antibiotics. Both cell lines
were maintained in 37°C incubators in the presence of
water-saturated 5% CO2/95% air. Caco-2 cell medium
was replaced at 2-day intervals. TER was measured with
an EVOM equipped with STX probes.
Virus and containment
All experiments used a low passage stock of the
ZH501 strain of RVF virus that was obtained from USAM-
RIID. All experiments that used infectious virus were
carried out under biosafety level-4 containment at the
CDC.
Immunoprecipitations
For immunoprecipitation experiments assessing RVF
virus entrance polarity, Caco-2 cells were infected from
either apical or basolateral chambers with RVF virus at a
multiplicity of infection (m.o.i.) of 10 in culture medium
lacking FCS. At 1 h postinfection, the inoculum was
removed and replaced with complete medium. At 16 h
postinfection, the medium was removed from both cham-
bers and replaced with MEM lacking cysteine and me-
thionine, supplemented with 20% dialyzed FCS (labeling
medium) in the apical chamber and labeling medium
plus 100 Ci Tran35S-label in the basolateral chamber. At
20 h postinfection apical and basolateral media were
collected and divided into two samples each and diluted
1:1 with 2 RIPA buffer (1 RIPA: 150 mM NaCl, 50 mM
Tris, pH 8, 1% NP-40, 0.5% deoxycholate, 0.1% sodium
dodecylsulfate) cells were then washed once with phos-
phate-buffered saline (PBS) and scraped into 1 RIPA
buffer. Samples were frozen on dry ice and subjected to
2  106 RAD to ensure virus inactivation, prior to the
beginning of immunoprecipitation. Experiments assess-
ing RVF virus release were done in essentially the same
manner, except that cells were infected with RVF virus at
an m.o.i. of 10 from both the apical and the basolateral
chambers and labeling was carried out with 250 Ci
Tran35S-label in complete medium beginning at 4 h
postinfection.
Samples were then precleared by incubation for 1 h
with protein G–Sepharose, followed by centrifugation at
14,000g for 5 min in a microfuge. The supernatant was
removed to a fresh microfuge tube containing 1 L of
either anti-fibronectin or anti-RVF virus antibodies. Sam-
ples were incubated for 1 h at 4°C with end-over-end
agitation, at which point protein G–Sepharose was
added and the incubation was continued for an addi-
tional hour. Immune complexes were harvested by cen-
trifugation and washed three times with 1 RIPA buffer.
The final wash was removed and immune complexes
were solubilized in 1 Laemmli sample buffer (62.5 mM
Tris HCl, pH 6.8, 25% glycerol, 2% SDS, 0.01% bromphe-
nol blue, 5% -mercaptoethanol). Immunoprecipitated
complexes were resolved by SDS–PAGE, and the gels
were fixed, dried, and exposed to phosphoimager screens.
Screens were scanned with a STORM phosphoimager
and band intensities were quantified using ImageQuant
software (Amersham Pharmacia Biotech, Piscataway, NJ).
Immunofluorescence
Infection of Caco-2 cells for immunofluorescence was
performed in essentially the same manner as for radio-
labeling. At 16 h postinfection, cells were fixed with 2%
paraformaldehyde for 30 min at 4°C or 100% ethanol for
15 min at20°C. The fixative was removed and replaced
with PBS/1% bovine serum albumin and the cells were
then placed in wet ice and exposed to 2  106 RAD to
ensure virus inactivation. Cells fixed with paraformalde-
hyde were permeabilized with 0.2% TX-100 for 30 min at
room temperature. Samples were examined on a Zeiss
confocal microscope and the resulting images were pro-
cessed with Adobe Photoshop.
For experiments involving uptake of glycoprotein
monoclonal antibodies, Caco-2 cells were infected as
described above. At 16 h postinfection, apical and baso-
lateral chambers were washed twice with fresh medium.
The last wash was removed and replaced with fresh
medium with or without monoclonal antibodies that rec-
ognize either G1 or G2 glycoproteins. Cells were then
incubated at 37°C for 1 h, at which point the medium was
removed and both chambers were washed twice with
fresh medium prior to fixation with 2% paraformaldehyde
for 30 min at 4°C. Cells were irradiated, permeabilized,
and processed as described above. The glycoprotein
monoclonal antibodies were labeled with anti-mouse
Alexa A488 antibody. Samples were examined on a Zeiss
Axioplan Invert microscope (Zeiss, Thornwood, NY).
Infectious virus release assay
For viral release experiments, Caco-2 cells were in-
fected from either apical or basolateral chambers with
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RVF virus at an m.o.i. of 10 in culture medium lacking
FCS. At 1 h postinfection, the inoculum was removed and
the cells were washed twice with fresh medium. The last
wash was removed and replaced with complete culture
medium. Beginning at 8 h postinfection, the TER was
measured and medium from apical and basolateral
chambers was harvested. Cells were washed once with
PBS and then harvested by scraping into culture medium
lacking FCS. All samples were frozen at 80°C prior to
the performance of plaque assays.
RVF virus was plaqued on Vero cells by the carboxy-
methylcellulose overlay method. Cells were fixed with
formalin and plaques visualized with crystal violet, as
described elsewhere (Mahy and Kangro, 1996).
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